Entity type
Company
Filer Snapshot
Royalty Pharma plc
CIK 0001802768. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
183
Latest filing
28 May 2026
Industry
Pharmaceutical Preparations
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: Forms 3/4/5 owner position for RPRX. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
—
No parsed 13F portfolio row yet.
Browse latest 13FLargest parsed holding
—
Populates from the latest parsed 13F information table.
Open holding13D/G large stake
—
No recent parsed 13D/G stake row for this CIK.
Browse 13D/GInsider / owner context
RPRX
07 Apr 2025 ยท $0
Open owner pageSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Forms 3/4/5
View source filing
4 filed on 28 May 2026 for CIK 0001802768.
- Ticker symbols
- RPRX on Nasdaq
- SEC industry
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 110 East 59 Th Street, New York, NY, 10022
- State of incorporation
- United Kingdom
- Fiscal year-end
- 31 December
Identity
Who this page is about.
2 identity fields
SEC profile Static EDGAR profile fields. 2 profile fields
Filer intelligence
What SEC filings say about Royalty Pharma plc
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- Forms 3/4/5 show insider context for RPRX worth $0.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
Forms 3/4/5 insider context
RPRX
07 Apr 2025
Latest update
What changed recently for Royalty Pharma plc
Latest 13F period: Q1 2026. Open the source-backed page to inspect the fresh filing or facts context.
Update date
14 May 2026
Page type
Filer profile
Latest period
Q1 2026
Institutional portfolio context was refreshed from a 13F filing filed on 14 May 2026.
Benchmark Context
Benchmark context for this company
Royalty Pharma plc has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest 13F period: Q1 2026. That gives you a fresh baseline before you compare this company with peers.
- Latest company facts filing date: 06 May 2026.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
SEC filing record
CIK 0001802768 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
183
First seen
11 May 2021
Latest filing
28 May 2026
Entity
Company
Observed form types
10-K
10-Q
13F-NT
3
4
SCHEDULE 13G/A
Industry context: Pharmaceutical Preparations.
Latest Filings
Showing the latest 12 of 183 SEC filings for Royalty Pharma plc.
4
4 filing
- Filing date
- 28 May 2026
- Reporting date
- 26 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 21 May 2026
- Reporting date
- 20 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 15 May 2026
- Reporting date
- 14 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 15 May 2026
- Reporting date
- 14 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
13F-NT
13F-NT filing
- Filing date
- 14 May 2026
- Reporting date
- 31 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 08 May 2026
- Reporting date
- 06 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 08 May 2026
- Reporting date
- 06 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 08 May 2026
- Reporting date
- 06 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 08 May 2026
- Reporting date
- 06 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-Q
10-Q filing
- Filing date
- 06 May 2026
- Reporting date
- 31 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 30 Apr 2026
- Reporting date
- 28 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 02 Apr 2026
- Reporting date
- 01 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing